Zitt Matthias, Mühlmann Gilbert, Weiss Helmut, Kafka-Ritsch Reinhold, Oberwalder Michael, Kirchmayr Werner, Margreiter Raimund, Ofner Dietmar, Klaus Alexander
Department of General and Transplant Surgery, Innsbruck Medical University, Anichstrasse 35, 6020, Innsbruck, Austria.
Langenbecks Arch Surg. 2006 Aug;391(4):369-75. doi: 10.1007/s00423-006-0045-5. Epub 2006 May 6.
Colorectal cancer is one of the leading causes of cancer death. We analyzed the value of standardized, risk-independent postoperative surveillance.
Between 1995 and 2001, 564 patients with colorectal cancer underwent standardized oncologic resection. One hundred thirty-four were unable to take part in the surveillance program, while 430 patients were grouped as follows: group I (n=272, risk-independent follow-up), group II (n=113, follow-up at other departments), and group III (n=45, no follow-up).
The 5-year cancer-specific survival rate for UICC III and IV was significantly higher in group I (87%) as compared to group II (35%). In group I, the 5-year disease-free survival rate was 70%. Cancer recurrence occurred at mean 17 (+/-12) months after colorectal resection and yielded a 5-year survival rate of 63%. Reresection was performed in 17 (35%) patients, of whom ten remained disease-free (5-year survival rate, 91%). The money spent for one patient's 5-year follow-up was 1665.
A standardized, risk-independent follow-up program allows early diagnosis of asymptomatic recurrence of colorectal cancer. Reresection improves the 5-year survival rate in this setting.